Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

44 articles from the last 30 days matching "Parkinson Disease"

AdvocacyRSSApr 27

Supporting a loved one during Parkinson’s hallucinations

Parkinson's disease can cause hallucinations—seeing or hearing things that aren't really there—especially as the disease progresses or with certain medications. This article shares practical tips for family members and caregivers on how to respond calmly when a loved one experiences hallucinations and how to redirect them to safer, calmer activities.

WHY IT MATTERSHallucinations affect many people with Parkinson's disease and can be frightening for both patients and caregivers, so learning evidence-based strategies to manage these moments can reduce distress and improve quality of life for the whole family.
ℹ Good to knowParkinson's disease
NewsRSSApr 24

Words of wisdom for living well with Parkinson’s disease

A person with Parkinson's disease shares their experience living well with the condition after receiving deep brain stimulation surgery. They started a weekly walking group three years ago to stay active and connected with others. The article focuses on practical tips and lifestyle strategies for managing Parkinson's disease day-to-day.

WHY IT MATTERSThis firsthand account demonstrates how deep brain stimulation combined with regular physical activity and social engagement can help people with Parkinson's disease maintain quality of life and independence.
ℹ Good to knowParkinson's disease
Clinical trialRSSApr 24

AAN 2026: Tavapadon helps delay levodopa start in early Parkinson’s

A new experimental drug called tavapadon from AbbVie helped people with early Parkinson's disease delay or avoid starting levodopa, which is the standard treatment for this condition. In a completed Phase 3 trial called TEMPO-4, most people taking tavapadon long-term did not need to start levodopa, and those already taking it didn't need to increase their dose. This suggests tavapadon could be a helpful new option for managing early Parkinson's symptoms.

WHY IT MATTERSIf approved, tavapadon could allow people with early Parkinson's to delay levodopa therapy, potentially postponing side effects that come with long-term use of this standard medication.
💬 Ask your doctorParkinson's disease
NewsRSSApr 24

Parkinson’s psychosis and UTIs: Is there a connection?

Some people with Parkinson's disease experience hallucinations or false beliefs, which is called psychosis. However, sudden changes in thinking or behavior might actually be caused by a urinary tract infection (UTI) rather than Parkinson's itself. Learning to tell the difference between these two conditions helps doctors give the right treatment.

WHY IT MATTERSParkinson's patients experiencing sudden confusion or hallucinations need to know that a UTI could be the culprit—and treating the infection might resolve symptoms without changing Parkinson's medications.
💬 Ask your doctorParkinson's disease
← PreviousPage 3 of 3

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases